Omeros | Betriebsaufwand





Betriebsaufwand Veränderung Datum
Adma Biologics USD 83.21M 4.02M 2025-09
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Cytokinetics USD 196.12M 27.43M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Heron Therapeutics USD 38.47M 4M 2024-09
Immunic USD 25.73M 2.91M 2024-09
Insmed USD 513.55M 109.86M 2025-12
Knight Therapeutics CAD 89.06M 2.02M 2024-09
MacroGenics USD 67M 8M 2025-09
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 193.68M 27.32M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Rockwell Medical USD 30.41M 1.11M 2025-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
United Therapeutics USD 804.8M 5.79B 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12
Xoma USD 22.84M 1.67M 2024-09


Omeros Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.